United States · FDA National Drug Code directory
PANTOPRAZOLE SODIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-674_13ac2fea-63be-66a4-e063-6394a90a7b6b
- Product NDC
- 76420-674
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- PANTOPRAZOLE
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140910
- Source listing expiry
- 20261231
Source-listed ingredients
- PANTOPRAZOLE SODIUM — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-674-01) · 76420-674-01
- 10 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-674-10) · 76420-674-10
- 30 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-674-30) · 76420-674-30
- 60 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-674-60) · 76420-674-60
- 90 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-674-90) · 76420-674-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →